TMO vs XOM: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
VS
Exxon Mobil Corporation · Energy
$137.81
-45.0% upside to fair value
Grade C
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
XOM trades at a lower forward P/E
(22.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
XOM |
| Current Price |
$464.61 |
$137.81 |
| Fair Value Estimate |
$498.27 |
$75.80 |
| Upside to Fair Value |
+7.2%
|
-45.0%
|
| Market Cap |
$172.7B |
$571.2B |
| Forward P/E |
25.2x
|
22.8x
|
| EV / EBITDA |
19.1x
|
10.1x
|
| Price / Sales |
3.8x
|
1.8x
|
| Price / FCF |
25.6x
|
30.4x
|
| Revenue Growth YoY |
+6.2%
|
+2.6%
|
| Gross Margin |
39.4%
|
25.5%
|
| Operating Margin |
17.8%
|
9.0%
|
| Return on Equity |
13.3%
|
9.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.91%
|
3.29%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Exxon Mobil Corporation is a leading integrated oil and gas company with a durable competitive moat based on its scale, integration, advantaged long-life resources, proprietary technology, and irreplaceable infrastructure. The company is led by a long-tenured management team with a strong capital allocation track record focused on dividends and buybacks. Despite these strengths, Exxon is currentl…
Accumulation Zones
| Metric |
TMO |
XOM |
| Zone Low |
$373.70 |
$56.85 |
| Zone High |
$423.53 |
$64.43 |
| In Buy Zone? |
No
|
No
|